KPV
A short anti-inflammatory peptide derived from alpha-MSH for gut and skin inflammation.
KPV is a tripeptide fragment derived from alpha-melanocyte-stimulating hormone (alpha-MSH). Despite being just three amino acids long, it retains the potent anti-inflammatory properties of the parent hormone without its pigmentation effects. Research has focused on its applications in inflammatory bowel disease, skin inflammation, and general immune modulation.
Key Benefits
Anti-Inflammatory
Inhibits NF-kB signaling, one of the primary inflammatory pathways, reducing production of pro-inflammatory cytokines.
Gut Inflammation Relief
Research in colitis models shows significant reduction in intestinal inflammation and improved mucosal healing.
Skin Health
Studies demonstrate anti-inflammatory effects on skin conditions including dermatitis and wound-associated inflammation.
Antimicrobial
KPV has demonstrated direct antimicrobial activity against certain bacteria, potentially supporting gut microbiome balance.
Immune Modulation
Modulates immune cell activity without broad immunosuppression, targeting excessive inflammatory responses.
Research Dosing Information
Not FDA-approved. Oral administration is increasingly popular due to the gut-targeting benefits. The tripeptide structure may survive GI transit better than larger peptides. Research dosing varies significantly by route.
Research Summary
KPV research has focused primarily on inflammatory bowel conditions and skin inflammation. Studies in mouse models of colitis demonstrate dose-dependent reduction in inflammatory markers and improved tissue histology. The peptide works by entering cells and inhibiting NF-kB nuclear translocation. Additional research shows antimicrobial properties and potential applications in inflammatory skin conditions. Human clinical data is very limited.
Safety Considerations
- Not FDA-approved for any medical use.
- Limited human safety data.
- No melanin-stimulating effects despite being derived from alpha-MSH.
- Generally well-tolerated in animal studies.
- May interact with immunosuppressive medications.
Frequently Asked Questions
Will KPV cause skin darkening?
No. Although derived from alpha-MSH (which affects melanin), KPV is a small fragment that retains anti-inflammatory properties without melanocyte-stimulating effects.
Can KPV be taken orally?
Yes. As a tripeptide, KPV may have better oral bioavailability than larger peptides. Oral administration is increasingly used to target gut inflammation specifically.
How does KPV compare to BPC-157 for gut health?
They work through different mechanisms. BPC-157 promotes tissue healing and angiogenesis. KPV directly inhibits NF-kB inflammatory signaling. Some research protocols combine both for gut conditions.
Related Content
This page is for educational and research purposes only. It is not medical advice. Consult a healthcare professional before using any peptide or supplement. None of the statements on this page have been evaluated by the FDA.